Aurinia Pharmaceuticals Inc (AUPH)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$2.18B
EV to revenue ratio (TTM)
5.59
EV to ebitda
9.45
Financial Performance
Revenue (TTM)
$0.32B
Gross profit (TTM)
$0.24B
EBITDA
$0.19B
Profitability
Operating margin (TTM)
42.20%
Profit margin
97.70%
Return on assets (TTM)
15.30%
Return on equity (TTM)
61.40%
Per Share Metrics
Revenue per share (TTM)
$2.44
EPS
$2.28
Diluted EPS (TTM)
$2.28
Book value
$4.91
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
7.15
Trailing P/E
7.15
Forward P/E
11.82
PEG ratio
0
Price to sales ratio (TTM)
6.79
Price to book ratio (TTM)
3.39
Growth
Quarterly earnings growth (YoY)
13.90%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
0
Buy
5
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.34